GlassScriptPhysician profile
Hannah M Huddleston
NPI 1023285335
$485.62
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $139.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $88.17 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.27 | 2019 | |
| Pfizer INC. | $48.00 | 2019 | |
| Encore Dermatology INC. | $45.20 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $42.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $40.28 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $33.73 | 2020 | |
| Aclaris Therapeutics, INC. | $28.89 | 2019 | |
| Almirall LLC | $25.78 | 2019-2020 | |
| Galderma Laboratories, L.P. | $22.89 | 2020 | |
| Genentech USA, INC. | $17.00 | 2019 | |
| Lilly USA, LLC | $13.66 | 2020 | |
| Dermira, INC. | $11.42 | 2019 | |
| Glenmark Therapeutics INC. | $11.00 | 2019 | |
| Prugen, INC. Pharmaceuticals | $7.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Huddleston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.